[1]
|
原发性肝癌诊疗指南(2022年版) [J]. 肿瘤综合治疗电子杂志, 2022, 8(2): 16-53.
|
[2]
|
董菁菁, 王允野. γ-谷氨酰转肽酶与血小板比值指数与乙肝相关肝细胞癌预后的关系[J]. 中国实验诊断学, 2021, 25(6): 860-864.
|
[3]
|
Cheng, J., Wang, W., Zhang, Y., et al. (2014) Prognostic Role of Pre-Treatment Serum AFP-L3% in Hepatocellular Carcinoma: Systematic Review and Meta-Analysis. PLOS ONE, 9, e87011.
https://doi.org/10.1371/journal.pone.0087011
|
[4]
|
Tandon, P. and Garcia-Tsao, G. (2009) Prognostic Indicators in Hepatocellular Carcinoma: A Systematic Review of 72 Studies. Liver International: Official Journal of the International Association for the Study of the Liver, 29, 502-510.
https://doi.org/10.1111/j.1478-3231.2008.01957.x
|
[5]
|
Yang, Z., Ye, P., Xu, Q., et al. (2015) Elevation of Serum GGT and LDH Levels, Together with Higher BCLC Staging Are Associated with Poor Overall Survival from Hepato-cellular Carcinoma: A Retrospective Analysis. Discovery Medicine, 19, 409-418.
|
[6]
|
卿明. ALRI和NLR在乙肝相关肝细胞癌切除预后评估中的价值[D]: [硕士学位论文]. 泸州: 西南医科大学, 2019.
|
[7]
|
Yao, M., Zhao, J. and Lu, F. (2016) Alpha-Fetoprotein Still Is a Valuable Diagnostic and Prognosis Predicting Biomarker in Hepatitis B Virus In-fection-Related Hepatocellular Carcinoma. Oncotarget, 7, 3702-3708.
https://doi.org/10.18632/oncotarget.6913
|
[8]
|
Jian, Z., Lei, Y., Gao, X., et al. (2011) Plasma microRNA Panel to Diagnose Hepatitis B Virus-Related Hepatocellular Carcinoma. Journal of Clinical Oncology, 29, 4781-4788. https://doi.org/10.1200/JCO.2011.38.2697
|
[9]
|
Fan, J., Guo, W., Sun, Y.F., et al. (2018) Circulating Tumor Cells with Stem-Like Phenotypes for Diagnosis, Prognosis and Therapeutic Response Evaluation in Hepatocellular Carcinoma. Clinical Cancer Research, 24, 2203-2213.
|
[10]
|
Zhou, J., Huang, A. and Yang, X.R. (2016) Liquid Biopsy and Its Po-tential for Management of Hepatocellular Carcinoma. Journal of Gastrointestinal Cancer, 47, 157-167. https://doi.org/10.1007/s12029-016-9801-0
|
[11]
|
Lemoine, M., Shimakawa, Y., Nayagam, S., et al. (2016) The Gamma-Glutamyl Transpeptidase to Platelet Ratio (GPR) Predicts Significant Liver Fibrosis and Cirrhosis in Patients with Chronic HBV Infection in West Africa. Gut, 65, 1369-1376. https://doi.org/10.1136/gutjnl-2015-309260
|
[12]
|
Pang, Q., Xu, X.S., Zhang, J.Y., et al. (2015) FIB-4 as a Prog-nostic Model for Patients with Hepatitis B-Associated Hepatocellular Carcinoma. Hepatology, 62, 1325-1326. https://doi.org/10.1002/hep.27727
|
[13]
|
Pang, Q., Bi, J.B., Xu, X.S., et al. (2015) King’s Score as a Novel Prog-nostic Model for Patients with Hepatitis B-Associated Hepatocellular Carcinoma. European Journal of Gastroenterology & Hepatology, 27, 1337-1346.
|
[14]
|
Choi, W.M., Lee, J.H., Ahn, H., et al. (2015) Forns Index Predicts Recurrence and Death in Patients with Hepatitis B-Related Hepatocellular Carcinoma after Curative Resection. Liver International, 35, 1992-2000.
https://doi.org/10.1111/liv.12776
|
[15]
|
Sierko, E. and Wojtukiewicz, M.Z. (2004) Platelets and Angiogenesis in Malignancy. Seminars in Thrombosis and Hemostasis, 30, 95-108. https://doi.org/10.1055/s-2004-822974
|
[16]
|
Labelle, M., Begum, S. and Hynes, R.O. (2011) Direct Signaling be-tween Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes Metastasis. Cancer Cell, 20, 576-590.
https://doi.org/10.1016/j.ccr.2011.09.009
|
[17]
|
Bambace, N.M. and Holmes, C.E. (2011) The Platelet Contribution to Cancer Progression. Journal of Thrombosis and Haemostasis: JTH, 9, 237-249. https://doi.org/10.1111/j.1538-7836.2010.04131.x
|
[18]
|
Ferroni, P., Spila, A., D’alessandro, R., et al. (2011) Plate-let Activation and Vascular Endothelial Growth Factor 165 Release in Hepatocellular Cancer. Clinica Chimica Acta; In-ternational Journal of Clinical Chemistry, 412, 450-454.
https://doi.org/10.1016/j.cca.2010.11.026
|
[19]
|
Plantureux, L., Crescence, L., Dignat-George, F., et al. (2018) Ef-fects of Platelets on Cancer Progression. Thrombosis Research, 164, S40-S47. https://doi.org/10.1016/j.thromres.2018.01.035
|
[20]
|
Timp, J.F., Braekkan, S.K., Versteeg, H.H., et al. (2013) Epi-demiology of Cancer-Associated Venous Thrombosis. Blood, 122, 1712-1723. https://doi.org/10.1182/blood-2013-04-460121
|
[21]
|
Dunn, G.P., Old, L.J. and Schreiber, R.D. (2004) The Im-munobiology of Cancer Immunosurveillance and Immunoediting. Immunity, 21, 137-148. https://doi.org/10.1016/j.immuni.2004.07.017
|
[22]
|
Wu, L., Saxena, S., Awaji, M., et al. (2019) Tumor-Associated Neutrophils in Cancer: Going Pro. Cancers, 11, Article No. 564. https://doi.org/10.3390/cancers11040564
|
[23]
|
Chan, S.L., Chan, A.W., Chan, A.K., et al. (2017) Systematic Eval-uation of Circulating Inflammatory Markers for Hepatocellular Carcinoma. Liver International: Official Journal of the In-ternational Association for the Study of the Liver, 37, 280-289. https://doi.org/10.1111/liv.13218
|
[24]
|
De Larco, J.E., Wuertz, B.R. and Furcht, L.T. (2004) The Potential Role of Neutrophils in Promoting the Metastatic Phenotype of Tumors Releasing Interleukin-8. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 10, 4895-4900. https://doi.org/10.1158/1078-0432.CCR-03-0760
|
[25]
|
Ardi, V.C., Kupriyanova, T.A., Deryugina, E.I., et al. (2007) Human Neutrophils Uniquely Release TIMP-Free MMP-9 to Provide a Potent Catalytic Stimulator of Angiogenesis. Proceedings of the National Academy of Sciences of the United States of America, 104, 20262-20267. https://doi.org/10.1073/pnas.0706438104
|
[26]
|
Hu, B., Yang, X.R., Xu, Y., et al. (2014) Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma. Clin-ical Cancer Research, 20, 6212-6222.
https://doi.org/10.1158/1078-0432.CCR-14-0442
|
[27]
|
Pang, Q., Zhou, L., Qu, K., et al. (2018) Validation of In-flammation-Based Prognostic Models in Patients with Hepatitis B-Associated Hepatocellular Carcinoma: A Retrospective Observational Study. European Journal of Gastroenterology & Hepatology, 30, 60-70. https://doi.org/10.1097/MEG.0000000000001021
|
[28]
|
Hanigan, M.H. (2014) Gamma-Glutamyl Transpeptidase: Redox Regulation and Drug Resistance. Advances in Cancer Research, 122, 103-141. https://doi.org/10.1016/B978-0-12-420117-0.00003-7
|
[29]
|
Zilkens, C., Friese, J., Köller, M., et al. (2008) Hepatic Failure after Injury—A Common Pathogenesis with Sclerosing Cholangitis? European Journal of Medical Research, 13, 309-313.
|
[30]
|
Bao, M., Zhu, Q., Aji, T., et al. (2021) Development of Models to Predict Postoperative Complications for Hepatitis B Virus-Related Hepatocellular Carcinoma. Frontiers in Oncology, 11, Article ID: 717826.
https://doi.org/10.3389/fonc.2021.717826
|
[31]
|
Luo, D., Li, H., Hu, J., et al. (2020) Development and Validation of Nomograms Based on Gamma-Glutamyl Transpeptidase to Platelet Ratio for Hepatocellular Carcinoma Patients Reveal Novel Prognostic Value and the Ratio Is Negatively Correlated with P38MAPK Expression. Frontiers in Oncology, 10, Article ID: 548744.
https://doi.org/10.3389/fonc.2020.548744
|
[32]
|
Yang, D., Wu, H., Nong, W., et al. (2021) A New Model Based on Gamma-Glutamyl Transpeptidase to Platelet Ratio (GPR) Predicts Prognostic Outcome after Curative Resection of Soli-tary Hepatocellular Carcinoma. Clinics and Research in Hepatology and Gastroenterology, 45, Article ID: 101509. https://doi.org/10.1016/j.clinre.2020.07.014
|
[33]
|
Dai, T., Deng, M., Ye, L., et al. (2020) Prognostic Value of Com-bined Preoperative Gamma-Glutamyl Transpeptidase to Platelet Ratio and Fibrinogen in Patients with HBV-Related Hepatocellular Carcinoma after Hepatectomy. American Journal of Translational Research, 12, 2984-2997.
|